Literature DB >> 26754802

Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.

Yunyan Zhang1, Laura Jonkman2, Antoine Klauser2, Frederik Barkhof3, V Wee Yong4, Luanne M Metz4, Jeroen Jg Geurts2.   

Abstract

BACKGROUND: Lesions with different extents of myelin pathology are found at autopsy in multiple sclerosis (MS), but the differences are not discernible in magnetic resonance imaging (MRI).
OBJECTIVE: To determine whether analysis of the local spectrum in MRI is sensitive to lesion differences in myelin integrity.
METHODS: We imaged fresh brain slices from 21 MS patients using 1.5T scanners. White matter lesions were identified in T2-weighted MRI, matched to corresponding specimens, and then classified into five categories in histology: pre-active (intact myelin); active, chronic active, chronic inactive (complete demyelination); and remyelinated lesions. Voxel-based frequency spectrum was calculated using T2-weighted MRI to characterize lesion structure (image texture).
RESULTS: MRI texture heterogeneity resulting from all spectral scales was greater in completely demyelinated lesions than in myelin-preserved lesions (p = 0.02) and normal-appearing white matter (p < 0.01). Moreover, the spectral distribution pattern over low-frequency scales differentiated demyelinated lesions from remyelinated and pre-active lesions (p < 0.01), where different lesion types also showed distinct texture scales.
CONCLUSION: Using multi-scale spectral analysis, it may be possible for standard MRI to evaluate myelin integrity in MS lesions. This can be critical for monitoring disease activity and assessing remyelination therapies for MS patients.
© The Author(s), 2016.

Entities:  

Keywords:  Myelin integrity; clinical MRI; lesion type; multi-scale spectrum; multiple sclerosis

Mesh:

Year:  2016        PMID: 26754802     DOI: 10.1177/1352458515624771

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

Review 1.  Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Authors:  Laura E Jonkman; Boyd Kenkhuis; Jeroen J G Geurts; Wilma D J van de Berg
Journal:  Neurosci Bull       Date:  2019-02-21       Impact factor: 5.203

Review 2.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

3.  Fluid-attenuated inversion recovery magnetic resonance imaging textural features as sensitive markers of white matter damage in midlife adults.

Authors:  Maria-Eleni Dounavi; Audrey Low; Graciela Muniz-Terrera; Karen Ritchie; Craig W Ritchie; Li Su; Hugh S Markus; John T O'Brien
Journal:  Brain Commun       Date:  2022-05-05

Review 4.  The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies.

Authors:  Adriana Octaviana Dulamea
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

5.  Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates.

Authors:  Rebekah L Petroff; Christopher Williams; Jian-Liang Li; James W MacDonald; Theo K Bammler; Todd Richards; Christopher N English; Audrey Baldessari; Sara Shum; Jing Jing; Nina Isoherranen; Brenda Crouthamel; Noelle McKain; Kimberly S Grant; Thomas M Burbacher; G Jean Harry
Journal:  Environ Health Perspect       Date:  2022-09-14       Impact factor: 11.035

6.  MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis.

Authors:  Elizabeth N York; Sarah-Jane Martin; Rozanna Meijboom; Michael J Thrippleton; Mark E Bastin; Edwin Carter; James Overell; Peter Connick; Siddharthan Chandran; Adam D Waldman; David P J Hunt
Journal:  Brain Commun       Date:  2021-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.